Stem Cell Research
International Stem Cell Corporation's Human Parthenogenetic Stem Cells to be used in Germany in the Development of Treatments for Neural Disease
Published in Law and Health Weekly, March 15th, 2008
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany under a Material Transfer Agreement between International Stem Cell Corporation (ISCO) and the University of Wuerzburg.
"The fact that Dr. Mueller and the University of Wuerzburg have approved ISCO's human parthenogenetic stem cells for research is a strong validation of their value in creating therapeutic cells that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AdvaMed
AdvaMed Supports Key Changes to Disclosure Legislation - Anthem Blue Cross and Blue Shield in Kentucky
Anthem Blue Cross and Blue Shield's Member Health Index Named BlueWorks(R) Award Winner - Asthma
Case links death to environmental tobacco smoke - Asthma
Toxic Neglect: Mutual Funds Opposing Shareholder Resolutions on Chemicals in Products Ignore Financial Risks to Shareholders - Bally Total Fitness Holding Corporation
Bally Total Fitness Announces Settlement With SEC - Behavior
Blue Cross of California Honored with Two BlueWorks(R) Awards - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
